Rosacea Market: Current Analysis and Forecast (2021-2027)

The rosacea market is expected to register a CAGR of approx. 6% over the period of 2022-2028. Rosacea is a skin condition where a person's skin turns red, and the blood vessels become visible. It is most common in middle-aged women and is frequently misdiagnosed as allergies, acne, or other skin infections. The affected areas of the body are the nose and cheeks. Rosacea symptoms include small, red, pus-filled bumps that may flare up from time to time. Eye dryness, irritation, and swollen, reddened eyelids are experienced by about half of rosacea patients. Other symptoms include nose skin thickening (rhinophyma) and an enlarged nose. Rosacea primarily affects middle-aged women with fair skin. The global rosacea market can be attributed to the increasing prevalence of rosacea among the global population. For instance, according to Medical News Today, in 2022, Rosacea is a chronic inflammatory condition affecting the skin. It typically causes visible and enlarged blood vessels of the face, redness, and small pus-filled bumps. Research estimates that around 5.46% of trusted source adults worldwide live with rosacea. Still, doctors may mistake its symptoms for acne or psoriasis. Owing to these glaring statistics the rosacea market is anticipated to grow in the forthcoming year due to the growing elderly population as the prevalence of rosacea increased significantly with age. Furthermore, the rosacea market is anticipated to grow on account of rise in the availability of generic medicines for rosacea. In addition, the increasing government initiatives and investments in the treatment market are likely to aid the market growth. However, some of the restraints in the market including low diagnosis despite high prevalence are impeding the growth of this market all over the world.

Bausch Health Companies Inc, Amorepacific Corporation, Bayer Schering AG, Nestle (Galderma), Leo Pharma Inc, Hovione FarmaCiencia SA, Aclaris Therapeutics, Pfizer Inc., Sonoma Pharmaceuticals Inc., Mylan N.V, Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst drug classes, the antibiotics category accounted for the significant share in the market in 2020"

Based on the drug classes, the rosacea market is segmented into antibiotics, alpha agonists, retinoid, corticosteroids, immunosuppressants, and others. The antibiotics segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. For a long time, antibiotics have been used to treat the symptoms of rosacea. It has the ability to reduce the number of acne pimples as well as bacterial inflammation or redness around the acne pimples.

"Amongst mode of administration, the topical category is expected to witness considerable CAGR during the forecast period"

Based on mode of administration, the market is fragmented into topical and oral. The topical segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to Topical medications generally being prescribed as the first line of treatment form. Topical drugs are highly favored over other options because they are convenient and give better results.

"Amongst distribution channel, the hospitals pharmacies category is expected to witness considerable CAGR during the forecast period"

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & drug stores, and online sales. The hospital pharmacies segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe owing to the increased awareness of so many peoples about rosacea. Rosacea has no established origin. The patient suffering from rosacea gets good treatment in hospital and have fast recovery.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the rosacea market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the rosacea industry owing to the high government healthcare spending on pharmaceuticals and medical devices each year, as well as societal awareness and growing prevalence of cancer, availability of advanced treatment and as the disease tends to affect people with fair/light skin.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global rosacea market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.